Oak Ridge Investments LLC Travere Therapeutics, Inc. Transaction History

Oak Ridge Investments LLC

  • $1.18 Billion
  • Q1 2025

A detailed history of Oak Ridge Investments LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Oak Ridge Investments LLC holds 54,070 shares of TVTX stock, worth $1.16 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
54,070
Previous 52,599 2.8%
Holding current value
$1.16 Million
Previous $916,000 5.68%
% of portfolio
0.08%
Previous 0.07%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$17.07 - $23.75 $25,109 - $34,936
1,471 Added 2.8%
54,070 $968,000
Q4 2024

Jan 15, 2025
SELL
$13.65 - $19.85 $37,401 - $54,389
-2,740 Reduced 4.95%
52,599 $916,000
Q3 2024

Oct 28, 2024
SELL
$7.89 - $15.21 $17,713 - $34,146
-2,245 Reduced 3.9%
55,339 $774,000
Q2 2024

Jul 16, 2024
SELL
$5.26 - $8.28 $43,878 - $69,071
-8,342 Reduced 12.65%
57,584 $473,000
Q1 2024

May 01, 2024
BUY
$7.18 - $9.82 $55,601 - $76,046
7,744 Added 13.31%
65,926 $508,000
Q4 2023

Jan 16, 2024
SELL
$5.44 - $9.5 $87,758 - $153,254
-16,132 Reduced 21.71%
58,182 $523,000
Q3 2023

Oct 30, 2023
SELL
$7.64 - $17.25 $17,579 - $39,692
-2,301 Reduced 3.0%
74,314 $664,000
Q2 2023

Aug 07, 2023
SELL
$15.3 - $22.61 $52,555 - $77,665
-3,435 Reduced 4.29%
76,615 $1.18 Million
Q1 2023

Apr 14, 2023
SELL
$17.82 - $22.89 $69,979 - $89,889
-3,927 Reduced 4.68%
80,050 $1.8 Million
Q4 2022

Jan 24, 2023
SELL
$18.47 - $26.14 $57,090 - $80,798
-3,091 Reduced 3.55%
83,977 $0
Q3 2022

Nov 08, 2022
SELL
$22.91 - $28.63 $4,536 - $5,668
-198 Reduced 0.23%
87,068 $2.15 Million
Q2 2022

Jul 28, 2022
SELL
$20.94 - $30.01 $112,803 - $161,663
-5,387 Reduced 5.81%
87,266 $2.11 Million
Q1 2022

Apr 22, 2022
SELL
$23.61 - $30.6 $1.33 Million - $1.73 Million
-56,424 Reduced 37.85%
92,653 $2.39 Million
Q4 2021

Feb 01, 2022
SELL
$24.34 - $31.17 $67,227 - $86,091
-2,762 Reduced 1.82%
149,077 $4.63 Million
Q3 2021

Nov 05, 2021
SELL
$12.98 - $25.03 $40,614 - $78,318
-3,129 Reduced 2.02%
151,839 $3.68 Million
Q2 2021

Jul 30, 2021
SELL
$14.11 - $26.4 $118,566 - $221,839
-8,403 Reduced 5.14%
154,968 $2.26 Million
Q1 2021

May 12, 2021
SELL
$23.37 - $31.77 $27.1 Million - $36.8 Million
-1,159,778 Reduced 87.65%
163,371 $4.08 Million
Q1 2021

May 04, 2021
BUY
$23.37 - $31.77 $28.1 Million - $38.2 Million
1,201,073 Added 983.87%
1,323,149 $33 Million
Q4 2020

Feb 03, 2021
BUY
$19.17 - $27.87 $2.34 Million - $3.4 Million
122,076 New
122,076 $3.33 Million

Others Institutions Holding TVTX

# of Institutions
224
Shares Held
94.1M
Call Options Held
1.62M
Put Options Held
774K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.37B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Oak Ridge Investments LLC Portfolio

Follow Oak Ridge Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email